299 related articles for article (PubMed ID: 12682234)
1. Expression of the NF-kappa B target gene X-ray-inducible immediate early response factor-1 short enhances TNF-alpha-induced hepatocyte apoptosis by inhibiting Akt activation.
Osawa Y; Nagaki M; Banno Y; Brenner DA; Nozawa Y; Moriwaki H; Nakashima S
J Immunol; 2003 Apr; 170(8):4053-60. PubMed ID: 12682234
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice.
Imose M; Nagaki M; Naiki T; Osawa Y; Brenner DA; Asano T; Hayashi H; Kato T; Moriwaki H
Liver Int; 2003 Oct; 23(5):386-96. PubMed ID: 14708901
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes.
Osawa Y; Banno Y; Nagaki M; Brenner DA; Naiki T; Nozawa Y; Nakashima S; Moriwaki H
J Immunol; 2001 Jul; 167(1):173-80. PubMed ID: 11418646
[TBL] [Abstract][Full Text] [Related]
4. Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation.
Hatano E; Brenner DA
Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1357-68. PubMed ID: 11705740
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha-induced interleukin-8 production via NF-kappaB and phosphatidylinositol 3-kinase/Akt pathways inhibits cell apoptosis in human hepatocytes.
Osawa Y; Nagaki M; Banno Y; Brenner DA; Asano T; Nozawa Y; Moriwaki H; Nakashima S
Infect Immun; 2002 Nov; 70(11):6294-301. PubMed ID: 12379708
[TBL] [Abstract][Full Text] [Related]
6. IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival.
Wu MX; Ao Z; Prasad KV; Wu R; Schlossman SF
Science; 1998 Aug; 281(5379):998-1001. PubMed ID: 9703517
[TBL] [Abstract][Full Text] [Related]
7. Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells.
Arlt A; Grobe O; Sieke A; Kruse ML; Fölsch UR; Schmidt WE; Schäfer H
Oncogene; 2001 Jan; 20(1):69-76. PubMed ID: 11244505
[TBL] [Abstract][Full Text] [Related]
8. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
St-Germain ME; Gagnon V; Parent S; Asselin E
Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316
[TBL] [Abstract][Full Text] [Related]
9. The early response gene IEX-1 attenuates NF-kappaB activation in 293 cells, a possible counter-regulatory process leading to enhanced cell death.
Arlt A; Kruse ML; Breitenbroich M; Gehrz A; Koc B; Minkenberg J; Fölsch UR; Schäfer H
Oncogene; 2003 May; 22(21):3343-51. PubMed ID: 12761504
[TBL] [Abstract][Full Text] [Related]
10. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT.
Machuca C; Mendoza-Milla C; Córdova E; Mejía S; Covarrubias L; Ventura J; Zentella A
BMC Cell Biol; 2006 Feb; 7():9. PubMed ID: 16504042
[TBL] [Abstract][Full Text] [Related]
12. Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway.
Chandrasekar B; Mummidi S; Perla RP; Bysani S; Dulin NO; Liu F; Melby PC
Biochem J; 2003 Jul; 373(Pt 2):547-58. PubMed ID: 12729461
[TBL] [Abstract][Full Text] [Related]
13. PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis.
Burow ME; Weldon CB; Melnik LI; Duong BN; Collins-Burow BM; Beckman BS; McLachlan JA
Biochem Biophys Res Commun; 2000 May; 271(2):342-5. PubMed ID: 10799299
[TBL] [Abstract][Full Text] [Related]
14. Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation.
Liu H; Perlman H; Pagliari LJ; Pope RM
J Exp Med; 2001 Jul; 194(2):113-26. PubMed ID: 11457886
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt.
Schulze-Bergkamen H; Brenner D; Krueger A; Suess D; Fas SC; Frey CR; Dax A; Zink D; Büchler P; Müller M; Krammer PH
Hepatology; 2004 Mar; 39(3):645-54. PubMed ID: 14999683
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis.
Shishodia S; Koul D; Aggarwal BB
J Immunol; 2004 Aug; 173(3):2011-22. PubMed ID: 15265936
[TBL] [Abstract][Full Text] [Related]
17. Impaired PI3K/Akt activation-mediated NF-kappaB inactivation under elevated TNF-alpha is more vulnerable to apoptosis in vitiliginous keratinocytes.
Kim NH; Jeon S; Lee HJ; Lee AY
J Invest Dermatol; 2007 Nov; 127(11):2612-7. PubMed ID: 17522703
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop.
Kim S; Domon-Dell C; Kang J; Chung DH; Freund JN; Evers BM
J Biol Chem; 2004 Feb; 279(6):4285-91. PubMed ID: 14623898
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells.
Kobayashi S; Werneburg NW; Bronk SF; Kaufmann SH; Gores GJ
Gastroenterology; 2005 Jun; 128(7):2054-65. PubMed ID: 15940637
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells.
Oka N; Nakahara S; Takenaka Y; Fukumori T; Hogan V; Kanayama HO; Yanagawa T; Raz A
Cancer Res; 2005 Sep; 65(17):7546-53. PubMed ID: 16140916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
